Background No studies have examined the impact of the interval from conclusion of
neoadjuvant chemotherapy to surgery in breast cancer patients. This study was undertaken …

Background: There is a paucity of literature examining the impact of timing of surgery after
neoadjuvant chemotherapy. Objective: This study aimed to analyze the impact of the time …

Background The optimal time interval between the end of neoadjuvant systemic therapy
(NST) and breast surgery is still unclear. It is not known if a delay in surgery might influence …

Background The impact of length of time to surgery (TTS) on oncologic outcomes following
neoadjuvant chemotherapy (NAC) in breast cancer patients is unclear. We investigated the …

Background Delays in the initiation of therapy among patients with early stage breast cancer
(BC) can negatively affect outcomes. Patients treated with neoadjuvant systemic …

Background Although neoadjuvant chemotherapy (NCT) is standard therapy for locally
advanced breast cancer, it remains controversial for early-stage disease due to concerns …

Introduction Neoadjuvant chemotherapy in breast cancer is used to downstage locally
advanced and inoperable tumors. Expanded benefits of neoadjuvant chemotherapy include …

Purpose: This retrospective analysis aimed to identify whether breast cancer patients
receiving radiotherapy alone following a complete clinical remission (cCR) to neoadjuvant …

Background Characterization of breast cancer phenotypes has improved our ability to
predict breast cancer behavior. Triple-negative (TN) breast cancers have higher and earlier …

Background Timely administration of adjuvant chemotherapy for breast cancer is associated
with a survival benefit. Specific elements of surgical management may lead to delays …